ABEP as primary chemotherapy for Hodgkin's disease.

[1]  F. Behm,et al.  Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. , 1991, The New England journal of medicine.

[2]  M. Ro̸rth,et al.  Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours , 1991, The Lancet.

[3]  P. Selby,et al.  Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease. , 1990, British Journal of Cancer.

[4]  J. Wingard,et al.  Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Tucker,et al.  Risk of second cancers after treatment for Hodgkin's disease. , 1988, The New England journal of medicine.

[6]  M. Ratain,et al.  Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. , 1987, Blood.

[7]  H. Deeg,et al.  Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  A. Santoro,et al.  CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease. , 1986, Seminars in oncology.

[9]  G. Bonadonna,et al.  Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP , 1975, Cancer.

[10]  V. Devita,et al.  Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1970, Annals of internal medicine.

[11]  F. Cavalli.  A new Journal: why not? , 1990 .

[12]  M. Gore,et al.  Ch1vpp Combination Chemotherapy for Hodgkin's Disease: Long Term Results , 2022 .